This is the authors' abstract. We don't add key points for this paper.
tumor-infiltrating lymphocytes. Our results demonstrate that IGF1R promotes metastatic tumor initiation and progression in lung TME. Furthermore, our research indicates that IGF1R could be a potential biomarker for early prediction of drug response and clinical evolution in NSCLC patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Alfaro‐Arnedo et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: